Meeting
2019 ASCO Annual Meeting
Metformin use and pancreatic cancer survival in US veterans with diabetes mellitus: Are there racial differences?
Authors
Adetunji T. Toriola
Washington University School of Medicine in St. Louis, St. Louis, MO
Adetunji T. Toriola , Suhong Luo , Theodore Seth Thomas , Bettina F. Drake , Su-Hsin Chang , Kristen Marie Sanfilippo , Kenneth Robert Carson
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 4129)
DOI
10.1200/JCO.2019.37.15_suppl.4129
Abstract #
4129
Poster Bd #
234
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Impact of concurrent medications use on outcome of pancreatic cancer: SEER Medicare analysis.
First Author: Muhammad Shaalan Beg
Poster
2016 Genitourinary Cancers Symposium
Impact of metformin on outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database.
First Author: Lana Hamieh
Poster
2015 Gastrointestinal Cancers Symposium
Effect of metformin use on the survival outcomes in diabetic patients with resectable pancreatic cancer: A single-institutional experience and meta-analysis.
First Author: Chenwi Ambe
Poster
2023 ASCO Genitourinary Cancers Symposium
Survival in Black and non-Black patients with metastatic prostate cancer.
First Author: Nina Cheranda